In individuals with diabetes, the most frequently prescribed class of anti-diabetic drug was DPP-4 inhibitors, the second-most frequently prescribed drug was SU or glinides, and the third-most frequently prescribed drug was insulin (Figure 3b). This evidence concerns the gene DPP4 and diabetes mellitus.